FXAIX
Price
$260.37
Change
+$1.83 (+0.71%)
Updated
Jul 31 closing price
Net Assets
833.14B
SDYYX
Price
$17.92
Change
+$0.10 (+0.56%)
Updated
Jul 31 closing price
Net Assets
837.05M
Interact to see
Advertisement

FXAIX vs SDYYX

FXAIX vs SDYYX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. SDYYX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and SDYYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 833B vs. SDYYX (837M). SDYYX pays higher dividends than FXAIX: SDYYX (1.60) vs FXAIX (1.06). FXAIX was incepted earlier than SDYYX: FXAIX (15 years) vs SDYYX (11 years). SDYYX (0.93) is less costly to investors than FXAIX (0.01). SDYYX is a more actively managed with annual turnover of: 8.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than SDYYX: FXAIX (0) vs SDYYX (100000). FXAIX annual gain was more profitable for investors over the last year : 19.55 vs. SDYYX (0.01). FXAIX return over 5 years is better than : 82.96 vs. SDYYX (7.07).
FXAIXSDYYXFXAIX / SDYYX
Total Expense Ratio0.010.503%
Annual Report Gross Expense Ratio0.010.932%
Fund Existence15 years11 years-
Gain YTD10.1288.870114%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets833B837M99,522%
Annual Yield % from dividends1.061.6066%
Returns for 1 year19.550.01191,123%
Returns for 3 years70.2918.78374%
Returns for 5 years82.967.071,173%
Returns for 10 years284.67122.13233%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLGCX1.970.01
+0.51%
Saratoga Large Capitalization Growth C
BERIX14.38-0.01
-0.07%
Carillon Chartwell Real Income I
PCCGX12.40-0.03
-0.24%
Victory Pioneer Mid Cap Value C
ERSMX29.37-0.20
-0.68%
Eaton Vance Atlanta Capital SMID-Cap R
FBTCX34.49-0.83
-2.35%
Fidelity Advisor Biotechnology C